The Lymph&Co Foundation works with the motto “Away with Lymphoma”.

In our vision innovation is the solution to the current major challenges in the treatment of patients with malignant lymphoma. It starts with the launch of innovative and excellent research and ends with social impact: development of new tools for the prevention, diagnosis and treatment of disease. The key is excellence.

The Lymph&Co Foundation supports groundbreaking scientific research that may lead the way to the cure or the improved therapeutic management of lymphoma. Lymph&Co has three types of grants, i.e. the Lymph&Co Research Grant, a Consortium Initiation Grant and the Paul Fentener van Vlissingen Lymphoma Fellowship.



Call for Research Proposals

The Lymph&Co Foundation intends to fund one or two research projects in 2021.
There will be a two-stage submission procedure for applications: pre-proposals and full proposals. The call is open since 29 April 2020. The deadline for submitting the pre-proposals is 14 July 2020.

More information on the emphasis of the call, timeline, eligibility and funding prerequisites is available on the dedicated page for the Lymph&Co Research Grant. Proposals can be submitted using the preproposal form, which can be downloaded from the website.



Innovative research benefits from the collaboration between different research groups supplying different expertise in consortia working on one project. Lymph&Co supports the formation of research consortia with a small Consortium Initiation grant. Grant applications can be submitted continuously to the secretariat using the grant application form available on the Consortium Initiation grant page.



The Paul Fentener van Vlissingen fellowship aims to support a young, talented physician or researcher to get additional training in particular research areas and further develop his/her skills and knowledge of lymphoma. Grant applications can be submitted continuously to the secretariat. See the dedicated page for the felllowship for information and forms.